Pentamidine inhibits Coxiella burnetii growth and 23S rRNA intron splicing in vitro

International Journal of Antimicrobial Agents

Volumn 36, Issue 4, 2010, Pages 380-382

  Minnick, Michael F ^a   Hicks, Linda D ^a   Battisti, James M ^a   Raghavan, Rahul ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

Coxiella; Group I intron; Pentamidine; RNA splicing

Indexed keywords

BACTERIAL RNA; PENTAMIDINE; RNA 23S;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; COXIELLA BURNETII; DRUG CYTOTOXICITY; DRUG TARGETING; GENE DISRUPTION; GENETIC CONSERVATION; GENOTYPE; GROWTH INHIBITION; HOST CELL; IN VITRO STUDY; INTRON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; RNA SPLICING;

ANIMALS; CERCOPITHECUS AETHIOPS; COXIELLA BURNETII; GENES, RRNA; HUMANS; INTRONS; MICROBIAL SENSITIVITY TESTS; PENTAMIDINE; Q FEVER; RNA SPLICING; RNA, RIBOSOMAL, 23S; VERO CELLS;

EID: 77955919402     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.05.017     Document Type: Article

References (15)

1. Moos A., Hackstadt T. Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect Immun 1987, 55:1144-1150.
2. Maurin M., Raoult D. Q fever. Clin Microbiol Rev 1999, 12:518-553.
3. Regis E. The biology of doom: the history of America's secret germ warfare project 1999, Henry Holt & Co., New York, NY.
4. Karakousis P.C., Trucksis M., Dumler J.S. Chronic Q fever in the United States. J Clin Microbiol 2006, 44:2283-2287.
5. Raoult D., Houpikian P., Dupont H.T., Riss J.M., Arditi-Djiane J., Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 1999, 159:167-173.
6. Raghavan R., Miller S.R., Hicks L.D., Minnick M.F. The unusual 23S rRNA gene of Coxiella burnetii: two self-splicing group I introns flank a 34-base-pair exon, and one element lacks the canonical omegaG. J Bacteriol 2007, 189:6572-6579.
7. Miletti K.E., Leibowitz M.J. Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition. Antimicrob Agents Chemother 2000, 44:958-966.
8. Coleman S.A., Fischer E.R., Howe D., Mead D.J., Heinzen R.A. Temporal analysis of Coxiella burnetii morphological differentiation. J Bacteriol 2004, 186:7344-7352.
9. Conte J.E., Upton R.A., Lin E.T. Pentamidine pharmacokinetics in patients with AIDS with impaired renal function. J Infect Dis 1987, 156:885-890.
10. Raghavan R., Hicks L.D., Minnick M.F. A unique group I intron in Coxiella burnetii is a natural splice mutant. J Bacteriol 2009, 191:4044-4046.
11. Rolain J.-M., Maurin M., Raoult D. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii. Antimicrob Agents Chemother 2001, 45:301-302.
12. Bronner U., Doua F., Ericsson Ö., Gustafsson L.L., Miézan T.W., Rais M., et al. Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'lvoire. Trans R Soc Trop Med Hyg 1991, 85:608-611.
13. Zhang Y., Bell A., Perlman P.S., Leibowitz M.J. Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae. RNA 2000, 6:937-951.
14. Zhang Y., Li Z., Pilch D.S., Leibowitz M.J. Pentamidine inhibits catalytic activity of group I intron Ca.LSU by altering RNA folding. Nucleic Acids Res 2002, 30:2961-2971.
15. Glaumann H., Bronner U., Ericsson Ö., Gustafsson L.L., Rombo L. Pentamidine accumulates in rat liver lysosomes and inhibits phospholipid degradation. Pharmacol Toxicol 1994, 74:17-22.